Lv1
60 积分 2025-11-25 加入
Abstract P5-04-28: Subtype by PAM50 changes after Neoadjuvant Endocrine therapy, from A Phase III Randomized, Double-Blind, Neoadjuvant Study of Hormonal Therapy plus Palbociclib versus Hormonal Therapy plus Placebo in ER+HER2- Operable Breast Cancer
5个月前
已关闭
Non-viral, high throughput genetic engineering of primary immune cells using nanostraw-mediated transfection
5个月前
已完结
皖公网安备34019202002308
